Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)
Olga P. Nyssen(Hospital Universitario de La Princesa), Ignasi Puig(Universitat de Vic - Universitat Central de Catalunya), Judith Gómez Camarero(Hospital Universitario de Burgos), Perminder Phull(Aberdeen Royal Infirmary), Blas José Gómez Rodríguez(Hospital Universitario Virgen Macarena), José Carlos Machado(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Mārcis Leja, José María Huguet, Juan Ortuño(Hospital Universitari i Politècnic La Fe), Н. Н. Дехнич(Smolensk State Medical University), O V Zaytsev, Inés Modolell(Consorci Sanitari de Terrassa), Rinaldo Pellicano(Fondazione Ricerca Molinette), Mónica Perona(Hospital Quirónsalud Barcelona), György Miklós Buzás, Ante Tonkić(University of Split), Manuel Castro‐Fernández(Hospital Universitario de Valme), Pilar Mata Romero(Hospital San Pedro de Alcántara), Theodore Rokkas(Henry Dunant Hospital), Vassiliki Ntouli(Tzaneion General Hospital), Marina Roldan Lafuente(Hospital General Universitari de Castelló), Jorge Pérez-Lasala(Hospital Universitario HM Sanchinarro), Zdenki Kikec(Šolski center Slovenj Gradec), Alfredo J. Lucendo, Laimas Virginijus Jonaitis(Lithuanian University of Health Sciences), Cem Şimşek(Johns Hopkins University), Marino Venerito(University Hospital Magdeburg), Juozas Kupčinskas(Lithuanian University of Health Sciences), Manuel Domínguez‐Cajal(Hospital General San Jorge), Óscar Núñez(Hospital General de La Rioja), С. А. Алексеенко(Far Eastern State Medical University), Oleg Shvets(Bogomolets National Medical University), Sotirios D. Georgopoulos(Athens Medical Center), Luis Fernández‐Salazar(Hospital Clínico Universitario de Valladolid), Frode Lerang(Østfold Hospital Trust), Nataša Brglez Jurečič(IEDC-Bled School of Management), Luís Bujanda(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), María Caldas(Hospital Universitario de La Princesa), Bojan Tepeš(Rogaška Medical Centre), Miguel Areia(Instituto Português de Oncologia Francisco Gentil), Д.С. Бордин(Moscow State University of Medicine and Dentistry), Ángeles Pérez‐Aísa(Agencia Sanitaria Costa del Sol), İlkay Şımşek(Dokuz Eylül University), Irina Voynovan(Moscow Clinical Scientific Center), Jesus Barrio(Hospital Universitario Río Hortega), Л. Г. Вологжанина, Galina Fadeenko, Luı́s Rodrigo(Hospital Universitario Central de Asturias), Tatiana Ilchishina, Frédéric Heluwaert(Centre Hospitalier Annecy Genevois)
Cited by 91
Related Papers
Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report
|Gut|2012|2.3k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
|Gastroenterology|2014|487
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309